CORONAVIRUS

More questions for J&J vaccine boosters ahead of FDA review

Oct 14, 2021, 5:52 AM
FILE: In this photo illustration, Health Department employee, Janet Gerber, holds the first vial of...
FILE: In this photo illustration, Health Department employee, Janet Gerber, holds the first vial of the Janssen COVID-19 vaccine at Louisville Metro Health and Wellness headquarters on March 4, 2021, in Louisville, Kentucky. (Photo Illustration by Jon Cherry/Getty Images)
(Photo Illustration by Jon Cherry/Getty Images)

WASHINGTON (AP) — The Food and Drug Administration is wrestling with whether and when to offer another dose of the single-shot Johnson & Johnson COVID-19 vaccine, while a new study out Wednesday raises the prospect that using a different brand as the booster might work better.

In an online review posted Wednesday, FDA scientists didn’t reach a firm conclusion about whether there’s enough evidence for J&J boosters, citing shortcomings with the company’s data and little information on protection against the extra-contagious delta variant of the coronavirus.

The review comes ahead of meetings Thursday and Friday when an FDA advisory panel will recommend whether to back booster doses of both the J&J and Moderna vaccines. That’s one step in the government’s vaccine review process: Next week, the FDA will make a final decision on authorizing those boosters and then the Centers for Disease Control and Prevention will debate who actually should get them.

Adding to the complexity is whether it’s OK to use a booster that’s a different brand than someone’s initial shots. Preliminary results of a U.S. government study suggest that mixing and matching boosters will work at least as well — and maybe far better for J&J recipients. Those people had a stronger immune response if they got either a Moderna or Pfizer shot as their booster than if they received another dose of the J&J vaccine, according to results posted online Wednesday. Mix-and-match is also up for discussion by the FDA panel this week.

Health authorities say all the vaccines used in the U.S. continue to provide strong protection against severe disease or death from COVID-19. But amid signs that protection against milder infections may be waning, the government already has cleared booster doses of the Pfizer vaccine for certain people starting at six months after their last shot.

Aiming for uniform recommendations, Moderna likewise asked the FDA to clear its booster dose at six months. But J&J complicated the decision by proposing a second shot over a range of two to six months.

FDA reviewers wrote that a study of the two-month booster plan suggests “there may be a benefit,” while pointing to only small numbers of people who got another shot at six months instead.

Overall, the J&J vaccine “still affords protection against severe COVID-19 disease and death,” the FDA’s reviewers concluded. But data about its effectiveness “are consistently less” than the protection seen with Pfizer and Moderna shots.

For its part, J&J filed data with the FDA from a real-world study showing its vaccine remains about 80% effective against hospitalizations in the U.S.

J&J’s single-dose vaccine was highly anticipated for its one-and-done formulation. But its rollout was hurt by a series of troubles including manufacturing problems and some rare but serious side effects including a blood clot disorder and a neurological reaction called Guillain-Barre syndrome. In both cases, regulators decided the shot’s benefits outweighed those risks.

Rival drugmakers Pfizer and Moderna have provided the vast majority of U.S. COVID-19 vaccines. More than 170 million Americans have been fully vaccinated with those companies’ two-dose shots while less than 15 million Americans got the J&J shot.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

KSL 5 TV Live

Top Stories

Coronavirus

...
Ashley Moser

Utah family hasn’t seen father in nearly 1,000 days due to COVID-19 travel restrictions

“None of us were expecting to not see him three years later,” a daughter shares how her Father remains in China.
17 hours ago
People line up for nucleic acid testing in Sanya, 'China's Hawaii', on August 6. (VCG/Getty Images)...
Simone McCarthy and CNN's Beijing bureau

Covid lockdown strands 80,000 tourists in ‘China’s Hawaii’

Around 80,000 tourists are stranded in the popular resort city of Sanya on China's tropical Hainan island after authorities announced lockdown measures to stem an outbreak of Covid-19.
4 days ago
TOKYO, JAPAN - JUNE 29: Women in rental kimonos walk through the Asakusa area on June 29, 2022 in T...
Lilit Marcus, CNN

Japan is open to travel. So why aren’t tourists coming back?

Even though Japan partially reopened its borders for tourists, only about 1,500 visitors went to the country during its peak travel season.
11 days ago
President Joe Biden removes his mask as he delivers remarks on the Inflation Reduction Act of 2022 ...
ZEKE MILLER, Associated Press

Biden tests positive for COVID-19, returns to isolation

The White House says President Joe Biden tested positive for COVID-19 again Saturday, slightly more than three days after he was cleared to exit coronavirus isolation.
12 days ago
ATLANTA, GA - UNDATED:  This undated handout photo from the Centers for Disease Control and Prevent...
Jed Boal

U of U researcher joins international team to confirm specific origin of COVID-19

New research released Tuesday confirmed the origin of COVID-19. A University of Utah Health and an international team of researchers found that the earliest cases of COVID-19 in humans emerged at a wholesale fish market in Wuhan, China in December 2019.
16 days ago
U.S. President Joe Biden gives the thumbs up while reacting to questions from the press about how h...
CHRIS MEGERIAN, Associated Press

Doctor: Biden’s COVID symptoms ‘almost completely resolved’

President Joe Biden's COVID-19 symptoms have “almost completely resolved," according to a new note from his doctor released Monday.
17 days ago

Sponsored Articles

tips how to quit smoking...

7 Tips How to Quit Smoking | Quitting Smoking Might be One of the Hardest Things You Ever Do but Here’s Where You Can Start

Quitting smoking cigarettes can be incredibly difficult. Here are 7 tips how to quit smoking to help you on your quitting journey.
Photo: Storyblocks...
Blue Stakes of Utah 811

Blue Stakes of Utah 811: 5 Reasons To Call 811 Before You Dig When Working in Your Yard

Call before you dig. Even at home, you could end up with serious injuries or broken utilities just because you didn't call Blue Stakes of Utah 811.
Days of...
Days of '47 Rodeo

TRIVIA: How well do you know your rodeo? Take this quiz before you go to the Days of ’47!

The Utah Days of ’47 Rodeo presented by Zions Bank is a one-of-a-kind Gold Medal Rodeo being held July 20-23, 25 at 7:30 PM. The Days of ’47 Rodeo How well do you know your rodeo trivia? Take the quiz to test your know-all before heading out to the Days of ’47 Rodeo at the […]
cyber security through multi factor authentication setup...
Les Olson IT

How multi factor authentication setup helps companies stay safe

Multi factor authentication (MFA) setup is an important security measure that every company should implement for their workers. It’s also wise to install it for your personal and home accounts.
...
Lighting Design

Check out these stunning lamps with stained glass shades

Lamps with stained glass shades are statement pieces that are more than simply aesthetic. They also meet a functional requirement: to light up a room.
Address Bar of internet browser shows internet access...
AARP Utah

Utah voters 50+ support increased access to Internet

The AARP surveyed Utah voters aged 50 plus about internet access and if they support the expansion of broadband, especially in rural areas currently lacking it.
More questions for J&J vaccine boosters ahead of FDA review